Active Screening of Multi-Drug Resistant Bacteria Effectively Prevent and Control the Potential Infections

Cell Biochemistry and Biophysics

Volumn 71, Issue 2, 2015, Pages 1235-1238

  Ren, Yuguo ^a   Ma, Guoliang ^a   Peng, Lin ^a   Ren, Yufeng ^b   Zhang, Fengmei ^a  

^a Laiwu People s Hospital   (China)

^b Department of Internal Medicine Fangxia Hospital of Laicheng District   (China)

Author keywords

Active screening; Effectiveness evaluation; Multi drug resistance; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL INFECTIONS; BACTERIUM; CROSS INFECTION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PRECLINICAL STUDY; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 84925533251     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0333-6     Document Type: Article

References (25)

1. Liu, Y., et al. (2013). Multi-drug resistant gram-negative enteric bacteria isolated from flies at Chengdu Airport, China. Southeast Asian Journal of Tropical Medicine and Public Health,44(6), 988–996.
2. Bargiacchi, O., et al. (2014). Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: Case reports and review. Infection,42(5), 801–809.
3. Neveur, M. (2013). Multi-drug resistant bacteria in the home. Revue de I’infirmiere,192, 24–26.
4. Vonberg, R. P., et al. (2008). Epidemiology of multi-drug-resistant gram-negative bacteria: Data from an university hospital over a 36-month period. International Journal of Hygiene and Environmental Health,211(3–4), 251–257.
5. El-Kafrawy, U., et al. (2013). Effectiveness of a neonatal intensive care unit access intercom linked audiovisual display monitor highlighting infection control procedures. American Journal of Infection Control,41(8), 749–750.
6. Alvarez-Lerma, F., et al. (2014). Epidemiological study of Clostridium difficile infection in critical patients admitted to the intensive care unit. Medicina intensiva/Sociedad Espanola de Medicina Intensiva y Unidades Coronarias,. doi:10.1016/j.medin.2013.11.007.
7. Yamakawa, K., et al. (2011). Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan. BMC Infectious Diseases,11, 303.
8. Chuengchitraks, S., et al. (2010). Impact of new practice guideline to prevent catheter-related blood stream infection (CRBSI): Experience at the pediatric intensive care unit of Phramongkutklao Hospital. Journal of the Medical Association of Thailand,93(Suppl 6), S79–S83.
9. Teltsch, D. Y., et al. (2011). Infection acquisition following intensive care unit room privatization. Archives of Internal Medicine,171(1), 32–38.
10. Nseir, S., et al. (2005). First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Critical Care Medicine,33(2), 283–289.
11. Martins, S. T., et al. (2004). Application of control measures for infections caused by multi-resistant gram-negative bacteria in intensive care unit patients. Memorias do Instituto Oswaldo Cruz,99(3), 331–334.
12. Nwadike, V. U., Ojide, C. K., & Kalu, E. I. (2014). Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital ICU. African Journal of Infectious Diseases,8(1), 14–18.
13. Movahedi, Z., et al. (2013). Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran. Journal of Preventive Medicine and Hygiene,54(1), 24–28.
14. Walshe, C., et al. (2012). Culture positivity of CVCs used for TPN: Investigation of an association with catheter-related infection and comparison of causative organisms between ICU and Non-ICU CVCs. Journal of Nutrition and Metabolism,2012, 257959.
15. Boyer, J. M., et al. (2010). Nontuberculous mycobacterium infection in a burn ICU patient. Burns,36(7), e136–e139.
16. Diomidous, M., et al. (2013). Infection control and quality assurance of health services provided in ICU: Development of an ICU website. Studies in Health Technology and Informatics,190, 249–251.
17. Martin-Loeches, I., et al. (2011). Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Medicine,37(2), 272–283.
18. Gervais, C., et al. (2008). Experts recommendations on safety practices for ICU patients, excluding risk of infection. French-speaking society of intensive care. French society of anesthesia and resuscitation. Annales Francaises d’Anesthesie et de Reanimation,27(10), e43–e51.
19. Tomono, K. (2012). The managements of nosocomial outbreaks of multi-drug resistant bacteria. Nihon Rinsho,70(2), 320–323.
20. Latha, C., et al. (2009). Antiplasmid activity of 1′-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria. Journal of Ethnopharmacology,123(3), 522–525.
21. Drinka, P. J., & Crnich, C. J. (2005). An approach to endemic multi-drug-resistant bacteria in nursing homes. Journal of the American Medical Directors Association,6(2), 132–136.
22. Giannakaki, V., & Miyakis, S. (2012). Novel antimicrobial agents against multi-drug-resistant gram-positive bacteria: An overview. Recent Patents on Anti-Infective Drug Discovery,7(3), 182–188.
23. Liu, Y. N., & She, D. Y. (2010). Proper clinical counter-measures for multi-drug resistant bacteria. Zhonghua Yi Xue Za Zhi,90(46), 3244–3246.
24. Ridgway, J. P., et al. (2014). Sensitivity of surveillance testing for multidrug-resistant gram-negative bacteria in the intensive care unit. Journal of Clinical Microbiology,52(11), 4047–4048.
25. Sreeramoju, P. V., et al. (2008). Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery. Infection Control and Hospital Epidemiology,29(1), 51–56.